Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer

Clinical trial NCT04989283 · WITHDRAWN

Trial details

NCT number: NCT04989283
Sponsor: National Cancer Institute (NCI)
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Non-Small Cell Carcinoma Stage IIB Lung Cancer AJCC v8 Stage IIIA Lung Cancer AJCC v8 Superior Sulcus Lung Carcinoma

Start date: 2021-09-09
Primary completion: 2031-05-10
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.